Scientific Informatics & Analytical Platforms - software & AI news

Daily news on software, AI, and companies shaping scientific informatics & analytical platforms.

Showing 44 results
Minimalist illustration of a brain scan and AI model

Jul 15, 2026

Apple FaceID Co-Inventor Launches AI Brain Diagnostics Startup

Gidi Littwin, a former Apple engineer known for his role in developing FaceID, has launched a startup named Hemispheric, aiming to revolutionize brain diagnostics using AI. The company plans to create a sophisticated AI model that can diagnose neurological and psychiatric disorders, such as depression, PTSD, and Parkinson's disease, with the goal of making brain scans as routine and affordable as blood tests.Hemispheric's approach focuses on analyzing brain imaging data to identify patterns that
A minimalist representation of an HPLC column in a dark color scheme.

Jul 13, 2026

Why Is Agilent (NYSE:A) Launching New AI Chromatography Tools?

Agilent Technologies has recently expanded its laboratory product offerings by introducing new chromatography tools and AI-enabled software, enhancing its digital research capabilities.The launch includes an expansion of the Altura High Performance Liquid Chromatography (HPLC) column portfolio, which is crucial for separating and identifying compounds in various fields such as pharmaceuticals and environmental testing. These new products are designed to ensure consistent performance across diver
A molecular model and research notebook in a dimly lit lab

Jul 6, 2026

Why Dotmatics May Be Sitting at the Center of AI's Biggest Untapped Market

The intersection of AI and scientific research presents a significant opportunity, particularly for companies like Dotmatics that facilitate the integration of these technologies into existing workflows.As AI continues to evolve, the focus has largely been on the capabilities of various models. However, the true potential lies in how these models can be utilized effectively within industries, especially in scientific research. Historical patterns suggest that companies enabling the practical app
Minimalist representation of a data interface in a dark color scheme.

Jul 4, 2026

Is Revvity’s Claude Integration Deepening Its Software-Led R&D Strategy Enough To Matter For RVTY?

Revvity's integration of Claude into its Signals Software business marks a significant step in enhancing its research and development capabilities, potentially reshaping how scientists access and utilize complex data.In June 2026, Revvity announced its Signals Software's inclusion in Anthropic's Model Context Protocol (MCP) directory. This integration allows researchers to leverage Signals AI capabilities through Claude, facilitating a more intuitive interaction with scientific data. By acting a
A minimalist illustration of a laboratory vial and a molecule on a dark background.

Jun 25, 2026

Domino Data Lab and Appsilon Partner to Speed AI to Production for Life Sciences

Domino Data Lab and Appsilon have announced a partnership aimed at enhancing the deployment of AI in regulated environments within the life sciences sector.This collaboration is designed to streamline the transition from development in R and Python to validated production, leveraging Appsilon's expertise in open-source software and AI solutions tailored for pharmaceutical companies. The partnership addresses a common challenge faced by many life sciences organizations: the inability to effective
A minimalist illustration of a DNA strand and a computer chip in a dark theme.

Jun 25, 2026

/C O R R E C T I O N -- Domino Data Lab/

Domino Data Lab and Appsilon have announced a partnership aimed at enhancing the deployment of AI in the life sciences sector, addressing the challenges faced by organizations in moving from development to production.The collaboration focuses on leveraging open-source AI within regulated environments, which is crucial for pharmaceutical companies. By integrating Appsilon's expertise in R and Python with Domino's AI platform, the partnership aims to streamline the transition of data science proje
A biohazard waste container in a dimly lit lab setting, emphasizing the importance of safety in scientific research.

Jun 25, 2026

Nvidia (NVDA) Launches BioNeMo As Life Sciences Firms Roll Out Integrations

NVIDIA has unveiled its BioNeMo Agent Toolkit, a specialized AI platform aimed at enhancing life sciences research.This new toolkit is designed to empower scientific teams and AI agents to streamline experimental discovery through automation and reasoning capabilities. Several biotechnology and lab automation companies, such as Tecan and Simulations Plus, have already begun integrating their workflows with the BioNeMo platform, indicating a practical application within existing laboratory system
A minimalist illustration of a DNA strand and a computer chip in a dark palette.

Jun 24, 2026

NVIDIA launches BioNeMo Agent Toolkit; Tecan adopts for Lab AI

NVIDIA has unveiled its BioNeMo Agent Toolkit, aimed at enhancing scientific computing across various life sciences fields, including drug discovery and genomics. Tecan, a laboratory automation specialist, is among the first to adopt this technology, integrating it into its Introspect analytics platform.The BioNeMo toolkit incorporates NVIDIA's extensive life sciences libraries and models, enabling AI agents to perform tasks such as gathering evidence, running computational experiments, and eval
A test tube with a colorful liquid on a lab bench

Jun 24, 2026

How Revvity’s New Signals AI-Powered R&D Platform (RVTY) Has Changed Its Investment Story

Revvity, Inc. has recently enhanced its Signals One platform by integrating Signals AI, aiming to transform R&D data into actionable insights for scientists through natural language processing. This development marks a significant shift from a passive data repository to an active tool that aligns with researchers' workflows.With the incorporation of an intelligence layer based on structured scientific data and validated algorithms, Signals AI is expected to bolster Revvity's position in the soft
A protein sample in a vial on a lab bench with an open research notebook in the background.

Jun 22, 2026

Revvity focuses on biologics software strategy, shares trade quietly on the NYSE

Revvity is enhancing its Signals BioDesign software to streamline biologics research workflows, positioning itself competitively in the life sciences sector.Revvity Inc. has been actively developing its Signals software platform, particularly the Signals BioDesign component, aimed at optimizing complex biologic research processes. This software is designed to integrate with existing discovery platforms, enabling biopharma clients to efficiently manage data related to proteins, antibodies, and ad
A mass spectrometer in a laboratory setting

Jun 2, 2026

What Danaher (DHR)'s New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders

Danaher’s recent upgrades to its SCIEX mass spectrometry platform signal a strategic move towards enhancing its market position in life sciences through AI integration.SCIEX, a subsidiary of Danaher, has introduced significant enhancements to its ZenoTOF line and launched the novus V55 triple quadrupole mass spectrometer, both powered by the new AI-enabled SCIEX OS 5.0 software. These advancements aim to optimize complex laboratory workflows and improve sensitivity, thereby bolstering Danaher's
Open notebook with notes and a pen on a conference table

May 26, 2026

C Platform accelerates push into pharma and biotech AX market

C Platform is intensifying its efforts in the pharmaceutical and biotech sectors by hosting a seminar focused on AI-driven research and development strategies.During the seminar, C Platform collaborated with industry leaders HPE, W&B (Weights & Biases Korea), and NovaDX to explore the integration of AI infrastructure and MLOps platforms tailored to the unique requirements of R&D environments. Emphasizing the importance of these tools, C Platform highlighted how they can enhance return on investm